1. Agesen T.H., Sveen A., Merok M.A., Lind G.E., Nesbakken A., SkotheimR.I., Lothe R.A.: ColoGuideEx: A robust gene classifier specificfor stage II colorectal cancer prognosis. Gut, 2012; 61: 1560–7
2. Akishima-Fukasawa Y., Nakanishi Y., Ino Y., Moriya Y., KanaiY., Hirohashi S.: Prognostic significance of CXCL12 expression inpatients with colorectal carcinoma. Am. J. Clin. Pathol., 2009; 132:202–10
3. Alberts B., Johnson A., Lewis J., Morgan D., Raff M., Roberts K.,Walter K.: Molecular Biology of the Cell. Garland Science, NewYork 2015, 814–9
4. Alon R., Chen S., Fuhlbrigge R., Puri K.D., Springer T.A.: Thekinetics and shear threshold of transient and rolling interactionsof L-selectin with its ligand on leukocytes. Proc. Natl. Acad. Sci.USA, 1998; 95: 11631–6
5. Bachelerie F., Ben-Baruch A., Burkhardt A.M., Combadiere C.,Farber J.M., Graham G.J., Horuk R., Sparre-Ulrich A.H., Locati M.,Luster A.D., Mantovani A., Matsushima K., Murphy P.M., NibbsR., Nomiyama H. i wsp.: International Union of Basic and ClinicalPharmacology. LXXXIX. Update on the extended family of chemokinereceptors and introducing a new nomenclature for atypicalchemokine receptors. Pharmacol Rev., 2014; 66: 1–79